2024-05-31 23:06:08 ET
Moderna, Inc. (MRNA)
Bernstein's 40th Annual Strategic Decisions Conference
May 31, 2024 10:00 PM ET
Company Participants
Stephane Bancel - CEO
Conference Call Participants
Courtney Breen - Bernstein
Presentation
Courtney Breen
Hi, there, everyone. It's great to see you all on Friday of the conference. I'm Courtney Breen, I'm the U.S. biopharma analyst here at Bernstein. I am privileged today to be sharing the stage with Stephane Bancel, the CEO of Moderna. Stephane has been at the helm of Moderna for the last 13 years. It's been a period of great change and growth for Moderna, and we are thrilled to have him join us for this fireside.
We will first kick-off with a bit of a talk from Stephane some slides that he's prepared, and then we'll dive into Q&A. To make sure that this Q&A is as relevant to this audience as possible, please feel free to post additional questions through the pigeon hole, I’ll be making sure to check that so that we can make sure that we're answering as many of your questions as possible.
With that, I'll hand over to you, Stephane, and look forward to the conversation.
Stephane Bancel
Thank you so much. Good morning, everybody, and thank you so much for being here on the Friday. We really appreciate it. We, of course, will be making forward-looking statements, and you can find those on our website or SEC website. As all of you know by now, because of what happened during COVID, we started building Moderna 15 years ago, it is like yesterday, on this very interesting premise that we could potentially move medicine into digital medicine because mRNA is an information molecule....
Read the full article on Seeking Alpha
For further details see:
Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)